EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Brain inflammaging in the pathogenesis of late-life depression

Toshiaki Ishizuka, Wataru Nagata, Keiichi Nakagawa, Sayaka Takahashi

Human Cell · 2024

DOI: 10.1007/s13577-024-01132-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Cell, 2024. Verfasst von Toshiaki Ishizuka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan. tishizu@ndmc.ac.jp. Hauptthemen laut MEDLINE: Depression, Brain. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 124 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Late-life depression (LLD) is a prevalent mental disorder among older adults. Previous studies revealed that many pathologic factors are associated with the onset and development of LLD. However, the precise mechanisms that cause LLD remain elusive. Aging induces chronic inflammatory changes mediated by alterations of immune responses. The chronic systemic inflammation termed "inflammaging" is linked to the etiology of aging-related disorders. Aged microglia induce senescence-associated secretory phenotype (SASP) and transition to M1-phenotype, cause neuroinflammation, and diminish neuroprotective effects. In addition, there is an age-dependent loss of blood-brain barrier (BBB) integrity. As the BBB breakdown can lead to invasion of immune cells into brain parenchyma, peripheral immunosenescence may cause microglial activation and neuroinflammation. Therefore, it is suggested that these mechanisms related to brain inflammaging may be involved in the pathogenesis of LLD. In this review, we described the role of brain inflammaging in LLD. Pharmacologic approaches to prevent brain inflammaging appears to be a promising strategy for treating LLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DepressionBrainHumansMicrogliaBlood-Brain BarrierAgingMetabolic ReprogrammingTh17 CellsMaleFemaleAnimals

Stichwörter der Autor:innen

BBB breakdownInflammasome activationLate-life depressionMetabolic reprogrammingSenescence-associated secretory phenotype (SASP)

Autor:innen und Institutionen

  • Department of Pharmacology, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan. tishizu@ndmc.ac.jp.
  • Department of Pharmacology, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.

Zitieren

APA

Ishizuka, T., Nagata, W., Nakagawa, K., & Takahashi, S. (2024). Brain inflammaging in the pathogenesis of late-life depression. Human Cell. https://doi.org/10.1007/s13577-024-01132-4

Vancouver

Ishizuka T, Nagata W, Nakagawa K, Takahashi S. Brain inflammaging in the pathogenesis of late-life depression. Human Cell. 2024. doi:10.1007/s13577-024-01132-4

BibTeX
@article{Ishizuka2024,
  author = {Ishizuka, Toshiaki and Nagata, Wataru and Nakagawa, Keiichi and Takahashi, Sayaka},
  title = {Brain inflammaging in the pathogenesis of late-life depression},
  journal = {Human Cell},
  year = {2024},
  doi = {10.1007/s13577-024-01132-4}
}
Kostenlos starten →